359 related articles for article (PubMed ID: 15280539)
1. TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells.
Perron MJ; Stremlau M; Song B; Ulm W; Mulligan RC; Sodroski J
Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11827-32. PubMed ID: 15280539
[TBL] [Abstract][Full Text] [Related]
2. Complex determinants within the Moloney murine leukemia virus capsid modulate susceptibility of the virus to Fv1 and Ref1-mediated restriction.
Ulm JW; Perron M; Sodroski J; C Mulligan R
Virology; 2007 Jul; 363(2):245-55. PubMed ID: 17343889
[TBL] [Abstract][Full Text] [Related]
3. The human TRIM5alpha restriction factor mediates accelerated uncoating of the N-tropic murine leukemia virus capsid.
Perron MJ; Stremlau M; Lee M; Javanbakht H; Song B; Sodroski J
J Virol; 2007 Mar; 81(5):2138-48. PubMed ID: 17135314
[TBL] [Abstract][Full Text] [Related]
4. Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha.
Hatziioannou T; Perez-Caballero D; Yang A; Cowan S; Bieniasz PD
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10774-9. PubMed ID: 15249685
[TBL] [Abstract][Full Text] [Related]
5. SUMO-interacting motifs of human TRIM5α are important for antiviral activity.
Arriagada G; Muntean LN; Goff SP
PLoS Pathog; 2011 Apr; 7(4):e1002019. PubMed ID: 21490953
[TBL] [Abstract][Full Text] [Related]
6. A novel envelope mediated post entry restriction of murine leukaemia virus in human cells is Ref1/TRIM5α independent.
Oliveira NM; Trikha R; McKnight Á
Retrovirology; 2010 Oct; 7():81. PubMed ID: 20929586
[TBL] [Abstract][Full Text] [Related]
7. Two surface-exposed elements of the B30.2/SPRY domain as potency determinants of N-tropic murine leukemia virus restriction by human TRIM5alpha.
Perron MJ; Stremlau M; Sodroski J
J Virol; 2006 Jun; 80(11):5631-6. PubMed ID: 16699044
[TBL] [Abstract][Full Text] [Related]
8. Disruption of human TRIM5alpha antiviral activity by nonhuman primate orthologues.
Berthoux L; Sebastian S; Sayah DM; Luban J
J Virol; 2005 Jun; 79(12):7883-8. PubMed ID: 15919943
[TBL] [Abstract][Full Text] [Related]
9. Trim5alpha protein restricts both HIV-1 and murine leukemia virus.
Yap MW; Nisole S; Lynch C; Stoye JP
Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10786-91. PubMed ID: 15249690
[TBL] [Abstract][Full Text] [Related]
10. Isolation of an active Lv1 gene from cattle indicates that tripartite motif protein-mediated innate immunity to retroviral infection is widespread among mammals.
Ylinen LM; Keckesova Z; Webb BL; Gifford RJ; Smith TP; Towers GJ
J Virol; 2006 Aug; 80(15):7332-8. PubMed ID: 16840314
[TBL] [Abstract][Full Text] [Related]
11. Proteasomal degradation of TRIM5alpha during retrovirus restriction.
Rold CJ; Aiken C
PLoS Pathog; 2008 May; 4(5):e1000074. PubMed ID: 18497858
[TBL] [Abstract][Full Text] [Related]
12. Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells.
Sokolskaja E; Berthoux L; Luban J
J Virol; 2006 Mar; 80(6):2855-62. PubMed ID: 16501094
[TBL] [Abstract][Full Text] [Related]
13. RING domain mutations uncouple TRIM5α restriction of HIV-1 from inhibition of reverse transcription and acceleration of uncoating.
Roa A; Hayashi F; Yang Y; Lienlaf M; Zhou J; Shi J; Watanabe S; Kigawa T; Yokoyama S; Aiken C; Diaz-Griffero F
J Virol; 2012 Feb; 86(3):1717-27. PubMed ID: 22114335
[TBL] [Abstract][Full Text] [Related]
14. Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction.
Stremlau M; Perron M; Welikala S; Sodroski J
J Virol; 2005 Mar; 79(5):3139-45. PubMed ID: 15709033
[TBL] [Abstract][Full Text] [Related]
15. Novel escape mutants suggest an extensive TRIM5α binding site spanning the entire outer surface of the murine leukemia virus capsid protein.
Ohkura S; Goldstone DC; Yap MW; Holden-Dye K; Taylor IA; Stoye JP
PLoS Pathog; 2011 Mar; 7(3):e1002011. PubMed ID: 21483490
[TBL] [Abstract][Full Text] [Related]
16. A human TRIM5alpha B30.2/SPRY domain mutant gains the ability to restrict and prematurely uncoat B-tropic murine leukemia virus.
Diaz-Griffero F; Perron M; McGee-Estrada K; Hanna R; Maillard PV; Trono D; Sodroski J
Virology; 2008 Sep; 378(2):233-42. PubMed ID: 18586294
[TBL] [Abstract][Full Text] [Related]
17. Virus-specific effects of TRIM5α(rh) RING domain functions on restriction of retroviruses.
Li X; Kim J; Song B; Finzi A; Pacheco B; Sodroski J
J Virol; 2013 Jul; 87(13):7234-45. PubMed ID: 23637418
[TBL] [Abstract][Full Text] [Related]
18. Retrovirus restriction by TRIM5alpha variants from Old World and New World primates.
Song B; Javanbakht H; Perron M; Park DH; Stremlau M; Sodroski J
J Virol; 2005 Apr; 79(7):3930-7. PubMed ID: 15767395
[TBL] [Abstract][Full Text] [Related]
19. Cyclophilin A renders human immunodeficiency virus type 1 sensitive to Old World monkey but not human TRIM5 alpha antiviral activity.
Keckesova Z; Ylinen LM; Towers GJ
J Virol; 2006 May; 80(10):4683-90. PubMed ID: 16641261
[TBL] [Abstract][Full Text] [Related]
20. Differential restriction of human immunodeficiency virus type 2 and simian immunodeficiency virus SIVmac by TRIM5alpha alleles.
Ylinen LM; Keckesova Z; Wilson SJ; Ranasinghe S; Towers GJ
J Virol; 2005 Sep; 79(18):11580-7. PubMed ID: 16140735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
